Clinical Trial Update: Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, placebo-controlled, single-center trial evaluating Cerebrolysin for language ability in non-fluent aphasia after stroke. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Yonsei University | Conditions: Stroke | Phase 4 | Status: RECRUITING